Abstract:Dexamethasone, a synthetic long-acting glucocorticoid, is routinely used for treating mothers at risk for preterm delivery. However, intrauterine overexposure to glucocorticoids induces low birth weight and cartilage dysplasia in offspring. Also, the "critical window" and safe dose of this treatment are largely unknown. This study investigated the course-, dose-, and stage-dependent toxic effects and the possible mechanisms of prenatal dexamethasone exposure (PDE) on fetal development and articular cartilage development. Pregnant mice (C57BL/6) received subcutaneous injection of dexamethasone (0.8 mg/kg d) once on gestational day (GD) 15 or once a day from GD 15 to 17, or received various doses of dexamethasone (0, 0.2, 0.8, and 1.2 mg/kg d) on GD 15-17, or received dexamethasone (0.8 mg/kg d) at early stage (GD 12-14) or late stage of pregnancy (GD 15-17). Offspring's knee joints were harvested at birth for morphological analyses and detection of gene expression. Repeated PDE significantly suppressed fetal and articular cartilage development, which were characterized by decreased body weight and body length, coarse articular cartilage surfaces, and reduced gene and protein expression of Col2a1 and aggrecan. For those newborns treated with repeated PDE at different doses, the toxic effects on fetal and articular cartilage development were observed at doses of 0.8 and 1.2 mg/kg d, whereas no obvious toxic effects were observed at the dose of 0.2 mg/kg d. Moreover, PDE at 0.8 mg/kg d during the early embryonic stage induced stronger toxic effects on fetal and articular cartilage development, compared with PDE during the late embryonic stage. Detection of gene expression showed that the TGFβ signaling pathway in the articular cartilage was down-regulated after PDE. Taken together, PDE induces fetal developmental toxicity and articular cartilage developmental toxicity in a course-, dose-, and stage-dependent manner.

Epigenetic Programming Mediates Abnormal Gut Microbiota and Disease Susceptibility in Offspring with Prenatal Dexamethasone Exposure.

Prenatal Dexamethasone Exposure Induced Alterations in Neurobehavior and Hippocampal Glutamatergic System Balance in Female Rat Offspring

Epigenetic Alterations Associated With Early Prenatal Dexamethasone Treatment

MiR-133a-3p/Sirt1 epigenetic programming mediates hypercholesterolemia susceptibility in female offspring induced by prenatal dexamethasone exposure

Programming Changes of Hippocampal Mir-134-5p/sox2 Signal Mediate the Susceptibility to Depression in Prenatal Dexamethasone-Exposed Female Offspring

Prenatal Dexamethasone Exposure-Induced a Gender-Difference and Sustainable Multi-Organ Damage in Offspring Rats Via Serum Metabolic Profile Analysis.

Dexamethasone exposure during pregnancy triggers metabolic syndrome in offspring via epigenetic alteration of IGF1

Prenatal dexamethasone exposure reduces osteoprogenitor proliferation in mice via histone modifications at the Mkp-1 gene locus

Prenatal Dexamethasone Exposure Induced Ovarian Developmental Toxicity and Transgenerational Effect in Rat Offspring.

Gestational dexamethasone exposure impacts hippocampal excitatory synaptic transmission and learning and memory function with transgenerational effects

Prenatal Dexamethasone Exposure Induces Anxiety- and Depressive-Like Behavior of Male Offspring Rats Through Intrauterine Programming of the Activation of NRG1-ErbB4 Signaling in Hippocampal PV Interneurons

MiR-466b-3p/HDAC7 meditates transgenerational inheritance of testicular testosterone synthesis inhibition induced by prenatal dexamethasone exposure

Dexamethasone As an Emerging Environmental Pollutant: Disruption of Cholesterol-Dependent Synaptogenesis in the Hippocampus and Subsequent Neurobehavioral Impacts in Offspring

Sex Difference in Adrenal Developmental Toxicity Induced by Dexamethasone and Its Intrauterine Programming Mechanism.

Transgenerational inheritance of adrenal steroidogenesis inhibition induced by prenatal dexamethasone exposure and its intrauterine mechanism

Dexamethasone induces developmental axon damage in the offspring hippocampus by activating miR-210-3p / miR-362-5p to target the aberrant expression of Sonic Hedgehog

Multi-organ developmental toxicity and its characteristics in fetal mice induced by dexamethasone at different doses, stages, and courses during pregnancy

Decreased H3K9ac Level of AT2R Mediates the Developmental Origin of Glomerulosclerosis Induced by Prenatal Dexamethasone Exposure in Male Offspring Rats.

Programming of a Developmental Imbalance in Hypothalamic Glutamatergic/gabaergic Afferents Mediates Low Basal Activity of the Hypothalamic-Pituitary-adrenal Axis Induced by Prenatal Dexamethasone Exposure in Male Offspring Rats.

Course-, Dose-, and Stage-Dependent Toxic Effects of Prenatal Dexamethasone Exposure on Fetal Articular Cartilage Development.

Cellular senescence mediates the detrimental effect of prenatal dexamethasone exposure on postnatal long bone growth in mice offspring